bexarotene has been researched along with urethane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, D; Lubet, RA; Wang, D; Wang, Y; Yao, R; You, M; Zhang, Z | 1 |
| Alyaqoub, FS; Gunning, WT; Kramer, PM; Liu, Y; Lubet, RA; Nines, R; Pereira, MA; Steele, VE | 1 |
| Alyaqoub, FS; Liu, Y; Lubet, RA; Pereira, MA; Steele, VE; Tao, L | 1 |
3 other study(ies) available for bexarotene and urethane
| Article | Year |
|---|---|
Prevention of lung cancer progression by bexarotene in mouse models.
Topics: Adenocarcinoma; Adenoma; Animals; Anticarcinogenic Agents; Bexarotene; Carcinogens; Carcinoma, Non-Small-Cell Lung; Disease Models, Animal; Disease Progression; Genes, p53; Genes, ras; Humans; Lung Neoplasms; Mice; Mice, Transgenic; Tetrahydronaphthalenes; Urethane | 2006 |
Prevention of mouse lung tumors by targretin.
Topics: Animals; Anticarcinogenic Agents; Bexarotene; Chemoprevention; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Mice; Neoplasms, Experimental; Nitrosamines; Tetrahydronaphthalenes; Urethane | 2006 |
Modulation by bexarotene of mRNA expression of genes in mouse lung tumors.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Bexarotene; DNA Methyltransferase 3A; Drug Administration Schedule; Female; Gene Expression Regulation, Neoplastic; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Mice; Mice, Inbred A; Peptides; Pulmonary Surfactant-Associated Protein C; RNA, Messenger; Tetrahydronaphthalenes; Tumor Burden; Urethane; Uteroglobin | 2008 |